首页> 外文OA文献 >GW26-e2303 Suboptimal oral anticoagulation use among Chinese nonvalvular Atrial Fibrillation Patients: the Nanchang Atrial Fibrillation project

【2h】

GW26-e2303 Suboptimal oral anticoagulation use among Chinese nonvalvular Atrial Fibrillation Patients: the Nanchang Atrial Fibrillation project

机译：GW26-e2303在中国非瓣膜性房颤患者中口服抗凝治疗效果欠佳：南昌房颤项目

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Xiong Qinmei; Shantsila Alena; Cheng Xiaoshu; Hong Kui; Lip Gregory YH;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Sex differences in clinical characteristics and inpatient outcomes among 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Project [J] . Xiong Qinmei, Shantsila Alena, Lane Deirdre A., International Journal of Cardiology . 2015,第Null期

机译：2442名住院非瓣膜性房颤患者的临床特征和住院结局的性别差异：南昌房颤项目
2. Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation The Chinese Atrial Fibrillation Registry Study [J] . Chang San-Shuai, Dong Jian-Zeng, Ma Chang-Sheng, Stroke: A Journal of Cerebral Circulation . 2016,第7期

机译：中国非瓣膜性心房颤动患者口服抗凝药的现状和时间趋势中国心房颤动注册研究
3. Response to Letter Regarding Article, "Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R(2)CHADS(2) Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts" [J] . Piccini Jonathan P., Stevens Susanna R., Chang YuChiao, Circulation: An Official Journal of the American Heart Association . 2013,第11期

机译：对有关“非瓣膜性房颤患者中风和全身性栓塞的预测指标：肾功能不全：ROCKET AF（Rivaroxaban每日一次，口服，直接因素）中的R（2）CHADS（2）指数的验证的答复Xa抑制与维生素K拮抗剂在房颤预防卒中和栓塞试验中的比较以及ATRIA（房颤的抗凝和危险因素）研究队列”
4. Self-management of Oral Anticoagulants by Patients with Atrial Fibrillation: How Effective and Safe Is It? [C] . R. Cazzin, P. Serra C. Lestuzzi International Workshop on Cardiac Arrhythmias . 2002

机译：心房颤动患者的口腔抗凝血剂自我管理：它有多效益和安全？
5. Optimal Post-Procedural Therapy for Patients Ineligble for Treatment with Oral Anticoagulatiion Who Undergo Left Atrial Appendage Occlusion with the Watchman Device for Non-Valvular Atrial Fibrillation [D] . Whitehead, Kristen Marie. 2020

机译：用口腔抗凝血治疗患者患者的最佳过程治疗患者患有左心房阑尾闭塞与鹰刀用于非瓣膜心房颤动
6. Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project [O] . Qinmei Xiong, Alena Shantsila, Juxiang Li, 2016

机译：中国非瓣膜性心房颤动患者口服抗凝治疗效果欠佳：南昌心房颤动项目
7. Sex differences in clinical characteristics and inpatient outcomes among 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Project [O] . Qinmei Xiong, Alena Shantsila, Deirdre A. Lane, 2015

机译：2442例住院治疗临床特征和住院成果的性差异：南昌心房颤动项目

GW26-e2303 Suboptimal oral anticoagulation use among Chinese nonvalvular Atrial Fibrillation Patients: the Nanchang Atrial Fibrillation project

著录项

引文网络

相似文献

相关主题

期刊订阅